Mary Grecco

DocwireNews

Results of a study that aimed to evaluate the feasibility of digital droplet polymerase chain reaction (ddPCR) to detect specific driver gene mutations (EGFR L858R/19del or KRAS-G12C/D) in circulating tumor (ct)DNA to monitor for molecular residual disease (MRD) in patients with resected NSCLC with the aforementioned mutations were presented at the ESMO Congress 2023.The study included 300 patients with resected NSCLC whose median age was 62 years. Among them, 54% had the EGFR L858R mutation, 34% had the EGFR 19del mutation, 10% had the KRAS mutation, and the remaining 2% had multiple mutations. Among different gene mutations, the positive rates for MRD were 15% for EGFR L858R, 19% for EGFR 19del, and 18% for KRAS. According to the researchers&rsquo; binary logistic analysis, patients who received adjuvant therapy had a higher likelihood of MRD negativity (odds ratio [OR], 0.50; 95% CI, 0.27-0.95; P&lt;.05). Higher TNM stage was associated with a higher likelihood of MRD positivity (OR, 2.13; 95% CI, 1.51-2.99; P&lt;.001).The researchers concluded that their findings indicated ddPCR is a feasible option for detecting MRD in resected NSCLC with common driver genes. &ldquo;Considering the elevated prevalence of EGFR mutations in the Asian population, our personalized tumor-informed approach targeting EGFR may offer a cost-effective solution. Nevertheless, additional data are necessary to substantiate its efficacy.&rdquo;Source: Zhong R, Liang H, Jiang Y, et al. Personalized tumor-informed circulating tumor DNA (ctDNA) analysis for molecular residual disease (MRD) detection in resected non-small cell lung cancer (NSCLC) with common driver genes. Abstract of a poster presented at the ESMO Congress 2023; October 20-24, 2023; Madrid, Spain.

Eva Blondeaux, MD

Risk-Reducing Surgery Linked to Survival in Young BRCA Carriers

Genetics & Breast Cancer

Jordana Jampel

Successful HIV Viral Suppression With At-Home Administration

Modernization and the Rising Burden of IBD: New Insights From a Global Study

Gastroenterology

Latest News

Digital Droplet Polymerase Chain Reaction Detects Molecular Residual Disease in Resected NSCLC

ESMO 2023: Focus on Lung Cancer

A study aimed to evaluate the feasibility of ddPCR to detect specific driver gene mutations in patients with resected NSCLC.

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe